Stay updated on Isatuximab Combo in High-Risk Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Combo in High-Risk Myeloma Clinical Trial page.

Latest updates to the Isatuximab Combo in High-Risk Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision v3.4.2 was added and revision v3.4.1 was removed from the study record history.SummaryDifference0.1%

- Check20 days agoChange DetectedThe history shows an added Revision: v3.4.1 and a deleted Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThe record history page now includes a glossary toggle, color-coded diffs (green for additions, red for deletions), and a new revision label showing v3.4.0, replacing the previous v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check42 days agoChange DetectedThe Record History shows a new revision entry v3.3.4 and removal of v3.3.3. This is a minor version metadata change that does not affect study information or functionality.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed.SummaryDifference0.2%

- Check91 days agoChange DetectedA new version entry (13) dated 2025-11-18 was added with an updated Study Status and Revision: v3.3.2. The previous entry dated 2025-06-06 and Revision: v3.2.0 was removed.SummaryDifference0.5%

Stay in the know with updates to Isatuximab Combo in High-Risk Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo in High-Risk Myeloma Clinical Trial page.